Two cycles of neoadjuvant chemotherapy

DRUG2 trials

Sponsors

Seoul National University Hospital, Lei Li

Conditions

Adjuvant TherapyConcurrent ChemoradiotherapyFallopian Tube CancerLaparoscopyLaparotomyLocally Advanced Cervical CancerNeoadjuvant ChemotherapyObjective Response

Phase 2

NAC Followed by RH for the Treatment of LACC

Lei LiAdjuvant Therapy, Concurrent Chemoradiotherapy, Laparoscopy +6

Start: 2019-06-19End: 2025-06-01Target: 60Updated: 2019-06-20

Phase 3

Reduction Of Cycles of neOadjuvant Chemotherapy for Advanced Epithelial Ovarian, Fallopian and Primary Peritoneal Cancer

Seoul National University HospitalFallopian Tube Cancer, Ovarian Cancer Stage IIIC, Ovarian Cancer Stage IV +1

Start: 2018-12-19End: 2023-12-31Target: 298Updated: 2019-12-10

Related Papers

Impact of supradiaphragmatic lymphadenectomy on the survival of patients in stage IVB ovarian cancer with thoracic lymph node metastasis

Frontiers in Oncology2023-08-103 citations

Reduction of cycles of neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian or primary peritoneal cancer (ROCOCO): study protocol for a phase III randomized controlled trial.

2020-05-064 citations